XML 70 R60.htm IDEA: XBRL DOCUMENT v3.22.2
Equity - Additional Information (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2018
shares
Jul. 31, 2015
shares
Equity [Line Items]            
Authorized amount (in shares)         10,000,000 10,000,000
Stock repurchased and retired during period (in shares) 6,098,026 6,098,026        
Stock repurchased and retired during period (in dollars per share) | $ / shares $ 11.45 $ 11.45        
Common shares repurchased (in shares)   0 0      
Shares remaining available for repurchase (in shares) 2,878,289 2,878,289        
Unsettled Repurchases | $ $ 3,745,000 $ 3,745,000        
Series C cumulative convertible preferred, shares outstanding (in shares) 1,935,400 1,935,400   1,935,400    
Series C cumulative convertible preferred, liquidation preference | $ $ 96,770,000 $ 96,770,000   $ 96,770,000    
OP unit equivalent in common shares   1.13        
Partners' capital account (in units) 757,000 757,000        
Series C Cumulative Convertible Preferred Stock            
Equity [Line Items]            
Series C cumulative convertible preferred, shares outstanding (in shares) 1,935,400 1,935,400        
Preferred stock, dividend per annum (in dollars per share) | $ / shares   $ 3.25        
Series C cumulative convertible preferred, liquidation preference | $ $ 96,770,000 $ 96,770,000        
Convertible preferred stock, conversion ratio 2.4339 2.4339        
Preferred stock conversion, threshold conversion price percentage (at least) 1.25 1.25        
Forward Contracts            
Equity [Line Items]            
Number of shares sold (in shares)   3,649,023        
Proceeds from sale of stock | $   $ 38,492,000        
Share-based Payment Arrangement            
Equity [Line Items]            
Shares granted (in shares)   25,297 27,565      
Grant date fair value | $   $ 357,000 $ 300,000      
At-The-Market Program            
Equity [Line Items]            
Sale of stock, authorized amount (up to) | $       $ 350,000,000    
Common shares amount available for issuance | $ $ 294,985,000 294,985,000        
Underwritten Offering | Forward Contracts            
Equity [Line Items]            
Number of shares to be settled on a forward basis (in shares)       16,000,000    
Sale of stock (in dollars per share) | $ / shares       $ 12.11    
Shares to be settled on forward basis, aggregate value | $ $ 183,392,000 $ 183,392,000